Impact of ¹³¹I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma

By Tharp K.   Israel O.   Hausmann J.   Bettman L.   Martin W.   Daitzchman M.   Sandler M.   Delbeke D.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1435-1442

Springer Publishing Company

Access to resources Recommend Favorite

Value of ¹²⁴I-PET/CT in staging of patients with differentiated thyroid cancer

By Freudenberg L.   Antoch G.   Jentzen W.   Pink R.   Knust J.   Görges R.   Müller S.   Bockisch A.   Debatin J.   Brandau W.  

European Radiology, Vol. 14, Iss. 11, 2004-11 ,pp. : 2092-2098

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of risk for symptomatic sialadenitis by post-therapeutic dual ¹³¹I scintigraphy in patients with differentiated thyroid cancer

By Lee Sang   Lee Jeong   Kim Shin   Han Seon   Bae Won  

Annals of Nuclear Medicine, Vol. 27, Iss. 8, 2013-10 ,pp. : 700-709

Springer Publishing Company

Access to resources Recommend Favorite

Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer

By Okamoto Shozo   Shiga Tohru   Uchiyama Yuko   Manabe Osamu   Kobayashi Kentaro   Yoshinaga Keiichiro   Tamaki Nagara  

Annals of Nuclear Medicine, Vol. 28, Iss. 2, 2014-02 ,pp. : 81-87

Springer Publishing Company

Access to resources Recommend Favorite

Gallium SPECT/CT in lymphoma: the ups and downs of functional imaging

By Bar-Shalom Rachel  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1247-1249

Springer Publishing Company

Access to resources Recommend Favorite